Inventor · disambiguated record
Songzhu An
Also filed as: AN SONGZHU
12 granted patents·11 pending applications·42 citations·filing 1999–2022
88Inventor score
Top patents by PatentIndex Score
23 records- 0184US10238652B2Compounds for treatment of cancerCUREGENIX INC·Filed 2017·Granted Mar 26, 2019·4 cites·17 claims
- 0284US6919176B2Polypeptides and nucleic acids associated with cancerAMGEN INC·Filed 2001·Granted Jul 19, 2005·13 cites·12 claims
- 0381US9713612B2Compounds for treatment of cancerCUREGENIX INC·Filed 2014·Granted Jul 25, 2017·5 cites·36 claims
- 0479US9744169B2Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2014·Granted Aug 29, 2017·4 cites·28 claims
- 0576US10087181B2Compound as WNT signaling inhibitor, composition, and use thereofCUREGENIX INC·Filed 2016·Granted Oct 2, 2018·2 cites·11 claims
- 0676US9556144B2Compound as WNT signaling inhibitor, composition, and use thereofAN SONGZHU·Filed 2012·Granted Jan 31, 2017·4 cites·19 claims
- 0774US10285988B2Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2017·Granted May 14, 2019·1 cites·18 claims
- 0873US8785442B2Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereofAN SONGZHU·Filed 2011·Granted Jul 22, 2014·6 cites·9 claims
- 0970US10660889B2Compounds for treatment of cancerCUREGENIX INC·Filed 2019·Granted May 26, 2020·0 cites·11 claims
- 1067US2023201194A1Combination compositions for immunotherapyCUREGENIX INC·Filed 2022·Application pending·0 cites
- 1157US7189524B1Receptor ligands and methods of modulating receptorsAMGEN INC·Filed 2003·Granted Mar 13, 2007·3 cites·4 claims
- 1257US2021054466A1Tumor biomarkers and use thereofCUREGENIX CORP·Filed 2020·Application pending·0 cites
- 1356US2019209558A1Compounds for treatment of fibrosis diseasesCUREGENIX INC·Filed 2019·Application pending·0 cites
- 1456US2021128553A1Combination compositions for immunotherapyCUREGENIX CORP·Filed 2020·Application pending·0 cites
- 1553US2006073515A1Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the sameGOETZL EDWARD J·Filed 2002·Application pending·0 cites
- 1652US2003108931A1Polypeptides and nucleic acids associated with cancerTULARIK INC·Filed 2002·Application pending·0 cites
- 1750US2003027252A1Novel receptorsTULARIK INC·Filed 2001·Application pending·0 cites
- 1847US10287550B2Serum-free chemically defined cell culture mediumSTEMRD INC·Filed 2016·Granted May 14, 2019·0 cites·23 claims
- 1947US2005170397A1Novel receptorsTULARIK INC·Filed 2005·Application pending·0 cites
- 2047US2013089928A1Serum-Free Chemically Defined Cell Culture MediumAN SONGZHU·Filed 2011·Application pending·0 cites
- 2146US2018112273A1Tumor biomarkers and use thereofCUREGENIX CORP·Filed 2016·Application pending·0 cites
- 2246US2018153884A1Combination compositions for immunotherapyCUREGENIX CORP·Filed 2016·Application pending·0 cites
- 2333US6812335B1Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the sameUNIV CALIFORNIA·Filed 1999·Granted Nov 2, 2004·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Songzhu An files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →